Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

US Patent 8067603 · Granted Nov 29, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fused heterocyclic derivatives as S1P modulators2020
Fused heterocyclic derivatives as S1P modulators2017
Fused heterocyclic derivatives as S1P modulators2015
1H-imidazole derivatives as cannabinoid CB2 receptor modulators2015
Fused heterocyclic derivatives as S1P modulators2014
1H-imidazole derivative having CB1, agonistic, CB1 partial agonistic or CB1 anta2014
Combination preparations comprising bifeprunox and a dopamine agonist2012
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor 2012
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor 2012
Combination preparations comprising SLV308 and a dopamine agonist2011
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists2010
Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists2010